Acorda: Hope after spinal injury

When Acorda Therapeutics Inc. founder Ron Cohen graduated from medical school in 1981, the clinical paradigm for neurological diseases was "diagnose and adios." Things have changed. While there are still no cures, or even effective treatments, there is enough scientific evidence to make the quest for therapies worth the effort.

The company's focus is on paraplegic and quadriplegic patients who have lost neurological function as a result of traumatic spinal cord injury. Acorda's core programs are in acute injury and in restorative therapy for chronic injury. Because no single technology is likely to address all the

Read the full 955 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE